Article information
Full text is only aviable in PDF
Bibliografía
[1.]
P.J. Brown, H.W. Greville, K.E. Finucane.
Asthma and irreversible airflow obstruction.
Thorax, 39 (1984), pp. 131-136
[2.]
P.J. Barnes, F.W. Liew.
Why does asthma become persistent?.
Am J Respir Crit Care Med, 153 (1996), pp. 23-25
[3.]
L.P. Boulet.
Airway remodelling in asthma.
Clin Asthma Rev, 1 (1997), pp. 55-62
[4.]
W.R. Roche.
Inflamatory and structural changes in the small airways in bronchial asthma.
Am J Care Med, 157 (1998), pp. 191-194
[5.]
J. Bousquet, P. Chanez, J.Y. Lacoste, et al.
Asthma: a disease remodeling the airways.
Allergy, 47 (1992), pp. 3-11
[6.]
B.R. Wiggs, C. Bosken, P.D. Paré, A. James, J.C. Hogg.
A model of airway narrowing in asthma and in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 145 (1992), pp. 1.251-1.258
[7.]
W.R. Roche, R. Beasley, J.H. Williams, S.T. Holgate.
Subepithelial fibrosis in the bronchi of asthmatics.
Lancet, i (1989), pp. 520-524
[8.]
C.E.P. Brewster, P.H. Howarth, R. Djukanovic, J. Wilson, S.T. Holgate, W.R. Roche.
Myofibroblasts and subepithelial fibrosis in bronchial asthma.
Am J Respir Cell Mol Biol, 3 (1990), pp. 507-511
[9.]
L.A. Laitinen, A. Laitinen, T. Haathela.
Airway mucosal inflammation even in patients with newly diagnosed asthma.
Am Rev Respir Dis, 147 (1993), pp. 697-704
[10.]
A. Chetta, A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, D. Oliveri.
Airways remodeling is a distinctive feature of asthma and is related to severity of disease.
Chest, 111 (1997), pp. 852-857
[11.]
C.R. Roberts.
Is asthma a fibrotic disease?.
Chest, 107 (1995), pp. 111-118
[12.]
C.R. Roberts, M. Okazawa, B. Wiggs, P.D. Paré.
Airway wall thickening.
Asthma, pp. 925-935
[13.]
A. Laitinen, A. Altraja, M. Linden, et al.
Treatment with inhaled budesonide and tensacin expression in bronchial mucosa of allergic asthmatics.
Am J Respir Crit Care Med, 149 (1994), pp. 942
[14.]
C.J. Trigg, N.D. Manolitsas, J. Wang, et al.
Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.
Am J Respir Crit Care Med, 150 (1994), pp. 17-22
[15.]
M. Hoshino, Y. Nakamura, J.J. Sim, et al.
Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expresion in bronchial asthma.
Clin Exp Allergy, 28 (1997), pp. 568-577
[16.]
T. Haahtela, M. Jarvinen, T. Kava, et al.
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
N Engl J Med, 331 (1994), pp. 700-705
[17.]
L. Agertoft, S. Pedersen.
Effects of long-term treatment with and inhaled corticosteroid on growth and pulmonary function in asthmatic children.
Respir Med, 88 (1994), pp. 373-381
[18.]
O. Selroos, A. Pientinalho, A.B. Lofroos, H. Riska.
Effect of early vs. late intervention with inhaled corticosteroids in asthma.
Chest, 108 (1995), pp. 1.228-1.234
[19.]
S. Pedersen, J.O. Warner, J.F. Price.
Early use of inhaled steroids in children with asthma.
Clin Exp Allergy, 27 (1997), pp. 995-1.006
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
